Theriva Biologics Statistics
Total Valuation
TOVX has a market cap or net worth of $12.05 million. The enterprise value is $1.28 million.
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026, before market open.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TOVX has 45.89 million shares outstanding. The number of shares has increased by 800.56% in one year.
| Current Share Class | 45.89M |
| Shares Outstanding | 45.89M |
| Shares Change (YoY) | +800.56% |
| Shares Change (QoQ) | +202.54% |
| Owned by Insiders (%) | 1.63% |
| Owned by Institutions (%) | 3.63% |
| Float | 45.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.59 |
| P/TBV Ratio | 0.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.17.
| Current Ratio | 1.74 |
| Quick Ratio | 1.69 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -137.82% and return on invested capital (ROIC) is -48.58%.
| Return on Equity (ROE) | -137.82% |
| Return on Assets (ROA) | -25.51% |
| Return on Invested Capital (ROIC) | -48.58% |
| Return on Capital Employed (ROCE) | -53.22% |
| Weighted Average Cost of Capital (WACC) | 5.59% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.58M |
| Employee Count | 16 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -80.93% in the last 52 weeks. The beta is 0.47, so TOVX's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | -80.93% |
| 50-Day Moving Average | 0.20 |
| 200-Day Moving Average | 0.31 |
| Relative Strength Index (RSI) | 59.16 |
| Average Volume (20 Days) | 17,587,728 |
Short Selling Information
The latest short interest is 6.86 million, so 14.96% of the outstanding shares have been sold short.
| Short Interest | 6.86M |
| Short Previous Month | 6.12M |
| Short % of Shares Out | 14.96% |
| Short % of Float | 15.20% |
| Short Ratio (days to cover) | 0.44 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -15.02M |
| Pretax Income | -23.74M |
| Net Income | -25.25M |
| EBITDA | -14.91M |
| EBIT | -15.02M |
| Earnings Per Share (EPS) | -$2.08 |
Full Income StatementBalance Sheet
The company has $13.06 million in cash and $2.63 million in debt, with a net cash position of $10.43 million or $0.23 per share.
| Cash & Cash Equivalents | 13.06M |
| Total Debt | 2.63M |
| Net Cash | 10.43M |
| Net Cash Per Share | $0.23 |
| Equity (Book Value) | 15.38M |
| Book Value Per Share | 0.43 |
| Working Capital | 7.45M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$16.67 million and capital expenditures -$35,000, giving a free cash flow of -$16.70 million.
| Operating Cash Flow | -16.67M |
| Capital Expenditures | -35,000 |
| Depreciation & Amortization | 108,000 |
| Net Borrowing | 1.44M |
| Free Cash Flow | -16.70M |
| FCF Per Share | -$0.36 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TOVX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -800.56% |
| Shareholder Yield | -800.56% |
| Earnings Yield | -215.67% |
| FCF Yield | -142.68% |
Analyst Forecast
The average price target for TOVX is $1.00, which is 280.81% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $1.00 |
| Price Target Difference | 280.81% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 26, 2024. It was a reverse split with a ratio of 1:25.
| Last Split Date | Aug 26, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
